S. D. Cook

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.

P. C. Dowling, Guanning Shang, S. Raval et al. · The Journal of Experimental Medicine · 1996 · 278 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study

Diego Cadavid, Leo Wolansky, Joan Skurnick et al. · Neurology · 2009 · 185 citations

Life Sciences, Immunology, Neurology +11

Quantitative functional measures in MS: What is a reliable change?

S. R. Schwid, Andrew Goodman, Michael McDermott et al. · Neurology · 2002 · 178 citations

Medicine, Neurology, Physical Medicine +17

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S. D. Cook, Patrick Vermersch, Gavin Giovannoni et al. · Multiple Sclerosis Journal · 2011 · 132 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Acanthamoeba keratitis: risk factors and outcome.

Chris Illingworth, S. D. Cook, C.H. Karabatsas et al. · British Journal of Ophthalmology · 1995 · 129 citations · Full text

Medicine, Infectious Diseases, Ophthalmology +17